A new round of booster shots to protect against the coronavirus could hit pharmacies and doctors’ offices as soon as next week. A U.S. Centers for Disease Control and Prevention immunization committee plans to meet on Sept. 12 with the Food and Drug Administration to review safety protocols for the shots and, potentially, sign off on them.

The expected rollout comes as COVID-19 transmission has increased nationally, as reflected in increased emergency room visits and hospitalizations around the country. Weekly emergency department visits for COVID began increasing the first week of July and hit a peak on Aug. 26, at 60,196 visits, with patients ages 0 to 1 years accounting for the majority of visits.

Pennsylvania is mirroring the national increase of visits with COVID illness according to data from the CDC. Wastewater results from Allegheny County show a 9% daily increase in viral markers for the week of Aug. 22 to 30 but, without accurate surveillance due to at-home tests eclipsing PCR tests, it is difficult to get a true sense of the prevalence of community transmission.

Respiratory viruses like coronavirus, in addition to influenza and RSV, tend to increase in colder months, putting the public at an apt period to prepare to get the next COVID vaccine when it becomes available. Experts suggest thinking of future COVID shots as recurrent ones to boost immunity, just as flu shots are offered every year and tailored to dominant strains.

Advertise with us

“Everybody’s immunity changes over time, no matter how you got the immunity,” said Dr. Donald Yealy, UPMC’s chief medical director and senior vice president of its Health Services division. “The vaccine gives the immune system a reminder to be prepared for the virus when it comes.”

Dr. Yealy said UPMC hospital systems reached the highest number of hospitalizations on Wednesday, Sept. 6, than in the past six months, but that the peak is still a fraction of what the county saw during the early days of Omicron.

Dr. Amy Crawford-Faucher, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, said she has not seen an influx of people coming into AHN hospitals with severe COVID illness, but she is hearing anecdotal reports of increased infections in addition to having more patients call in to report a positive at-home test and ask about symptom management.

She said the hospital system expects to have the vaccine available to the public by the end of September, and will offer it at the primary care and pediatric departments, similar to any other vaccine.

Coronavirus variants continue to mutate. Variants and subvariants thus far — such as EG.5, XBB.1.5 and 1.16, and the newer BA.2.86 — have evolved to be more transmissible and attach better to cells. The aforementioned variants have been labeled as Variants Being Monitored by the CDC as of Sept. 1. This means that previous vaccines and even previous COVID infections are less equipped to protect someone against changing variants, and is why new COVID vaccines are designed to target current variants.

Advertise with us

“The goal of the vaccine isn’t to prevent you from ever getting COVID-19,” said Dr. Yealy. “It’s just reassuring that, when you do come across it, you’re as prepared as possible … and making the immune system as ready as possible is the smartest thing you can do.”

He added that while immunity never goes away completely, it starts to substantially wane around six months after a vaccination, and that partial protection from a new vaccine has value, even for healthy people.

“It’s always worse to have a COVID-19 infection than a vaccination,” he said. Adverse reactions to the vaccine are rare compared to a swath of reported complications from COVID-19 disease.

Dr. Yealy, as well as Alfred L’Altrelli, the senior director of pharmacy at UPMC Presbyterian-Shadyside, expected the rollout to be on the timescale of days to weeks following the Sep. 12 meeting. Dr. Yealy said UPMC will contact the manufacturers same-day if the sign-off occurs.

In an email statement, Catherine Carter, head of media relations for Rite Aid, said the pharmacy was offering the previous bivalent shot and waiting on guidance and regulation about the new vaccine, which the CDC’s Advisory Committee on Immunization Practices will outline in its meeting.

Advertise with us

A big change from previous waves of COVID vaccine rollouts is the cessation of emergency declarations that allowed for some expedited decision-making: For instance, Allegheny County Health Department had access to previous versions of the vaccine prior to federal approval to allow for speedy rollout of the shots.

This time, though, institutions are waiting on the OK before gaining access. Another change: The cost of the vaccine also will not be covered by the government and is instead left up to private insurance and assistance programs. Officials expect insurance to cover the cost of shots, and that the CDC’s Bridge Access Program will catch costs for the un- and underinsured.

“I don’t think cost will be a significant concern,” said Dr. Yealy.

The University of Pittsburgh Vaccination and Health Connection Hub also offers vaccines in partnership with University Pharmacy. It offers flu and COVID shots for those 5 and up, and all vaccines for those 18 and up. Melissa McGivney, executive director of the Hub and a professor of pharmacy and therapeutics at Pitt, also said the Hub is waiting on guidelines about who will be eligible and when it can receive stock.

“As soon as it is available, we are going to be able to supply the needs of those we take care of,” said Ms. McGivney.

Advertise with us

Mr. L’Altrelli said that while federal involvement in the vaccines has dwindled following the cessation of emergency declarations, the vaccines are still safe and effective.

“The FDA, advisory committees and academic medical centers are still reviewing the data,” he said. “We still have safety and efficacy data to fall back on, and we have very promising data heading into this wave that this is a good time to get the vaccine,” he said.

Dr. Crawford-Faucher said that while she knows people are “boosted out” from the first round of shots, she encouraged people to think about the shot just like an annual flu shot.

“This is the best hope for what’s out there now,” she said.

Hanna Webster: hwebster@post-gazette.com